Evidence map›Paper›PMID 24991927›Full record

ArticlePLoS pathogens2014

Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection.

Béatrice Jacquelin, Gaël Petitjean, Désirée Kunkel, Anne-Sophie Liovat, Simon P Jochems, Kenneth A Rogers, Mickaël J Ploquin, Yoann Madec, Françoise Barré-Sinoussi, Nathalie Dereuddre-Bosquet and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Local genetic adaptation to habitat in wild chimpanzees.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. IL-15 induced bystander activation of CD8Frontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Role of NKG2a/ciScience · 2021
    Article
  19. CD32Frontiers in immunology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Béatrice JacquelinInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France.
Gaël PetitjeanInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France.
Désirée KunkelInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France.
Anne-Sophie LiovatInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France.
Simon P JochemsInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France.
Kenneth A RogersDivision of Pathology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Mickaël J PloquinInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France.
Yoann MadecInstitut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France.
Françoise Barré-SinoussiInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France.
Nathalie Dereuddre-BosquetCEA, Division of Immuno-Virology, DSV, iMETI, Fontenay-aux-Roses, France.
Pierre LebonSaint-Vincent de Paul Hospital & Paris Descartes University, Paris, France.
Roger Le GrandCEA, Division of Immuno-Virology, DSV, iMETI, Fontenay-aux-Roses, France.
François VillingerDivision of Pathology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Michaela Müller-TrutwinInstitut Pasteur, Regulation of Retroviral Infection Unit, Paris, France.
Institut Pasteur · FRCEA Paris-Saclay - Etablissement de Fontenay-aux-roses · FREmory University · USSorbonne Paris Cité · FRUniversité Paris Cité · FR

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
NIH HHS P51 OD011132
6 · The paper itself

Abstract

Chronic immune activation (IA) is considered as the driving force of CD4(+) T cell depletion and AIDS. Fundamental clues in the mechanisms that regulate IA could lie in natural hosts of SIV, such as African green monkeys (AGMs). Here we investigated the role of innate immune cells and IFN-α in the control of IA in AGMs. AGMs displayed significant NK cell activation upon SIVagm infection, which was correlated with the levels of IFN-α. Moreover, we detected cytotoxic NK cells in lymph nodes during the early acute phase of SIVagm infection. Both plasmacytoid and myeloid dendritic cell (pDC and mDC) homing receptors were increased, but the maturation of mDCs, in particular of CD16+ mDCs, was more important than that of pDCs. Monitoring of 15 cytokines showed that those, which are known to be increased early in HIV-1/SIVmac pathogenic infections, such as IL-15, IFN-α, MCP-1 and CXCL10/IP-10, were significantly increased in AGMs as well. In contrast, cytokines generally induced in the later stage of acute pathogenic infection, such as IL-6, IL-18 and TNF-α, were less or not increased, suggesting an early control of IA. We then treated AGMs daily with high doses of IFN-α from day 9 to 24 post-infection. No impact was observed on the activation or maturation profiles of mDCs, pDCs and NK cells. There was also no major difference in T cell activation or interferon-stimulated gene (ISG) expression profiles and no sign of disease progression. Thus, even after administration of high levels of IFN-α during acute infection, AGMs were still able to control IA, showing that IA control is independent of IFN-α levels. This suggests that the sustained ISG expression and IA in HIV/SIVmac infections involves non-IFN-α products.

Indexed as

AnimalsAntiviral AgentsChlorocebus aethiopsCytokinesGene Expression RegulationImmunity, InnateInflammationInterferon-alphaLymphocyte ActivationSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-LymphocytesAntiviral AgentsCytokinesInterferon-alpha

Identifiers

PMID24991927
PMCPMC4081777
OpenAlexW1989178685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.